![Sebastien Hazard](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Dr. Sebastien Hazard was previously employed as a Chief Medical Officer & Executive Vice President by Imunon, Inc., a Senior VP & Head-Clinical Development by Bicycle Therapeutics Plc, a Head-Clinical Development by GlaxoSmithKline Plc, and a Senior Medical Director-Clinical Development by Tesaro, Inc. He received his MBA from INSEAD.
Anciens postes connus de Sebastien Hazard
| Sociétés | Poste | Fin |
|---|---|---|
| BICYCLE THERAPEUTICS PLC | Corporate Officer/Principal | 01/09/2023 |
| GSK PLC | Directeur Technique/Scientifique/R&D | 01/04/2021 |
| TESARO INC | Directeur Technique/Scientifique/R&D | 01/05/2019 |
| IMUNON, INC. | Directeur Technique/Scientifique/R&D | - |
Formation de Sebastien Hazard
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
65
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Imunon, Inc.
 Imunon, Inc. BiotechnologyHealth Technology Engages in the provision of oncology drug development services | Health Technology |
Tesaro, Inc.
 Tesaro, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for cancer patients | Health Technology |
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
INSEAD
 INSEAD Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bicycle Therapeutics Plc
 Bicycle Therapeutics Plc Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops molecules and oncology medicines | Health Technology |
